Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iniparib in newly diagnosed malignant glioma
NCT00687765Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jul 2008
- Primary completion
- Jun 2015
- Countries
- 1
01
Overview
A Phase 2 trial of iniparib in glioblastoma (GBM), malignant glioma, sponsored by Sanofi. Started Jul 2008; status: completed.
02
Drugs
iniparib
03
Conditions
glioblastoma (GBM)malignant glioma
Beyond the preview
Go deeper on NCT00687765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00687765.